Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C19orf45 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ZNF280C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | TRIM34 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | MEPCE | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | LAMB2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | EPHA10 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SSPN | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | C2orf54 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PTGER3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ACOT4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |